Healthtech-focussed VC firm W Health Ventures has marked the first close of its second fund at ₹550 Cr ($60.6 Mn), with ambition to launch and scale businesses in the healthcare sector. The firm launched the fund in July 2025 with a target corpus of ₹600 Cr. It is targeting to back eight to ten early stage healthtech startups over the next four years, with an average cheque size of ₹30 Cr to ₹50 Cr each. Speaking with Inc42, W Health Ventures managing partner Pankaj Jethwani mentioned that the Fund II is “a company creation fund.” “We identify key problem statements, design solutions around them, and build companies to address those gaps. Many of these are platform businesses that already exist in the market but require varying levels of support,” he further explained. W Health Ventures launched cancer care platform Everhope Oncology via its venture studio 2070 Health in partnership with Narayana Health, in March 2025. The firm infused $10 Mn (about INR 86 Cr) in seed funding via its Fund II, along with the partner healthcare company to open new facilities in Delhi NCR and Mumbai. In the healthcare space, W Health’s second fund is focussed on exploring opportunities in… Read MoreInc42 Media
